10.00-10.15 Introduction- Martin Wilkins
Session 1 – 10.15-11.15 Clinical and pathophysiological insights (Dorian Haskard and Edwin Chilvers)
• Clinical experience. Cardiovascular sequelae and practice adaptation. (Ramzi Khamis)
• Impact on clinical trials (Rasha Al-Lamee)
• P-HOSP (Luke Howard)
Break: 11.15 to 11.30
Session 2 – 11.30-12.30 Drug discovery and evaluation (Sian Harding and Beata Wojciak-Stothard)
• Thrombosis in COVID-19- What have we learnt and treatment implication. (Mike Laffan)
• Endothelial pathophysiology- cross talk with thrombosis. (Anna Randi)
• Imaging ACE2 dimerization (Edwin Garcia/Paul French)
Lunch: 12.30 to 13.30
Session 3 – 13.30-15.00 Devices for remote diagnosis, monitoring and treatment (Fu Siong Ng and Mary Ryan)
• Biosensing platforms (Molly Stevens)
• Remote diagnostics and wearables (Patrik Bachtiger)
• Next generation Implantable devices (Zac Whinett)
• Assessment of cardiac function by the non-specialist (Peter Weinberg)
Break: 15.00 to 15.30
Session 4 – 15.30-17.00 Big data and cardiovascular health (Prapa Kanagaratnam and Ioanna Tzoulaki)
• COVID-19 Human Population SusceptibiliTY COHORT Network (COVIDITY-COHORT) (Ioanna Tzoulaki)
• Clinical data for research (Jamil Mayet)
• BCD: Big data, COVID and cardiovascular Disease (Jennifer Quint)
• Experience with a ‘Living lab’ and the ‘internet of things’ (Dave Sharp)
Keynote Lecture – 17.05- 17.30 Digital twin for cardiovascular disease – Professor Tim Chico, Professor of Cardiovascular Medicine, University of Sheffield

Closing remarks 17.30

Registration is now closed. Add event to calendar
See all events